Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance

Otto O. Yang, Ayub Ali, Noriyuki Kasahara, Emmanuelle Faure-Kumar, Jin Young Bae, Louis Picker, Haesun Park

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Cellular immunity is pivotal in HIV-1 pathogenesis but is hampered by viral sequence diversity. An approach to minimize this diversity is to focus immunity on conserved proteome sequences; therefore, we selected four relatively conserved regions (Gag amino acids 148 to 214 and 250 to 335, Env amino acids 521 to 606, and Nef amino acids 106 to 148), each created in three mosaics, to provide better coverage of M-group HIV-1 sequences. A conserved-region vaccine (CRV) delivering genes for these four regions as equal mixtures of three mosaics each (each region at a separate injection site) was compared to a whole-protein vaccine (WPV) delivering equimolar amounts of genes for whole Gag, Env, and Nef as clade B consensus sequences (separate injection sites). Three rhesus macaques were vaccinated via three DNA primes and a recombinant adenovirus type 5 boost (weeks 0, 4, 8, and 24, respectively). Although CRV inserts were about one-fifth that of WPV, the CRV generated comparable-magnitude blood CD4+ and CD8+ T lymphocyte responses against Gag, Env, and Nef. WPV responses preferentially targeted proteome areas outside the selected conserved regions in direct proportion to sequence lengths, indicating similar immunogenicities for the conserved regions and the outside regions. The CRV yielded a conserved-region targeting density that was approximately 5-fold higher than that of the WPV. A similar pattern was seen for bronchoalveolar lymphocytes, but with quadruple the magnitudes seen in blood. Overall, these findings demonstrate that the selected conserved regions are highly immunogenic and that anatomically isolated vaccinations with these regions focus immunodominance compared to the case for full-length protein vaccination.

Original languageEnglish (US)
Pages (from-to)1195-1204
Number of pages10
JournalJournal of Virology
Volume89
Issue number2
DOIs
StatePublished - 2015

Fingerprint

conserved sequences
Conserved Sequence
Human immunodeficiency virus 1
HIV-1
Vaccines
vaccines
injection site
Proteome
proteome
Proteins
Amino Acids
proteins
amino acids
Vaccination
vaccination
gag Genes
application coverage
Injections
consensus sequence
blood

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance. / Yang, Otto O.; Ali, Ayub; Kasahara, Noriyuki; Faure-Kumar, Emmanuelle; Bae, Jin Young; Picker, Louis; Park, Haesun.

In: Journal of Virology, Vol. 89, No. 2, 2015, p. 1195-1204.

Research output: Contribution to journalArticle

Yang, Otto O. ; Ali, Ayub ; Kasahara, Noriyuki ; Faure-Kumar, Emmanuelle ; Bae, Jin Young ; Picker, Louis ; Park, Haesun. / Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance. In: Journal of Virology. 2015 ; Vol. 89, No. 2. pp. 1195-1204.
@article{6268868434414d64b81478ed4e76b0d4,
title = "Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance",
abstract = "Cellular immunity is pivotal in HIV-1 pathogenesis but is hampered by viral sequence diversity. An approach to minimize this diversity is to focus immunity on conserved proteome sequences; therefore, we selected four relatively conserved regions (Gag amino acids 148 to 214 and 250 to 335, Env amino acids 521 to 606, and Nef amino acids 106 to 148), each created in three mosaics, to provide better coverage of M-group HIV-1 sequences. A conserved-region vaccine (CRV) delivering genes for these four regions as equal mixtures of three mosaics each (each region at a separate injection site) was compared to a whole-protein vaccine (WPV) delivering equimolar amounts of genes for whole Gag, Env, and Nef as clade B consensus sequences (separate injection sites). Three rhesus macaques were vaccinated via three DNA primes and a recombinant adenovirus type 5 boost (weeks 0, 4, 8, and 24, respectively). Although CRV inserts were about one-fifth that of WPV, the CRV generated comparable-magnitude blood CD4+ and CD8+ T lymphocyte responses against Gag, Env, and Nef. WPV responses preferentially targeted proteome areas outside the selected conserved regions in direct proportion to sequence lengths, indicating similar immunogenicities for the conserved regions and the outside regions. The CRV yielded a conserved-region targeting density that was approximately 5-fold higher than that of the WPV. A similar pattern was seen for bronchoalveolar lymphocytes, but with quadruple the magnitudes seen in blood. Overall, these findings demonstrate that the selected conserved regions are highly immunogenic and that anatomically isolated vaccinations with these regions focus immunodominance compared to the case for full-length protein vaccination.",
author = "Yang, {Otto O.} and Ayub Ali and Noriyuki Kasahara and Emmanuelle Faure-Kumar and Bae, {Jin Young} and Louis Picker and Haesun Park",
year = "2015",
doi = "10.1128/JVI.02370-14",
language = "English (US)",
volume = "89",
pages = "1195--1204",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance

AU - Yang, Otto O.

AU - Ali, Ayub

AU - Kasahara, Noriyuki

AU - Faure-Kumar, Emmanuelle

AU - Bae, Jin Young

AU - Picker, Louis

AU - Park, Haesun

PY - 2015

Y1 - 2015

N2 - Cellular immunity is pivotal in HIV-1 pathogenesis but is hampered by viral sequence diversity. An approach to minimize this diversity is to focus immunity on conserved proteome sequences; therefore, we selected four relatively conserved regions (Gag amino acids 148 to 214 and 250 to 335, Env amino acids 521 to 606, and Nef amino acids 106 to 148), each created in three mosaics, to provide better coverage of M-group HIV-1 sequences. A conserved-region vaccine (CRV) delivering genes for these four regions as equal mixtures of three mosaics each (each region at a separate injection site) was compared to a whole-protein vaccine (WPV) delivering equimolar amounts of genes for whole Gag, Env, and Nef as clade B consensus sequences (separate injection sites). Three rhesus macaques were vaccinated via three DNA primes and a recombinant adenovirus type 5 boost (weeks 0, 4, 8, and 24, respectively). Although CRV inserts were about one-fifth that of WPV, the CRV generated comparable-magnitude blood CD4+ and CD8+ T lymphocyte responses against Gag, Env, and Nef. WPV responses preferentially targeted proteome areas outside the selected conserved regions in direct proportion to sequence lengths, indicating similar immunogenicities for the conserved regions and the outside regions. The CRV yielded a conserved-region targeting density that was approximately 5-fold higher than that of the WPV. A similar pattern was seen for bronchoalveolar lymphocytes, but with quadruple the magnitudes seen in blood. Overall, these findings demonstrate that the selected conserved regions are highly immunogenic and that anatomically isolated vaccinations with these regions focus immunodominance compared to the case for full-length protein vaccination.

AB - Cellular immunity is pivotal in HIV-1 pathogenesis but is hampered by viral sequence diversity. An approach to minimize this diversity is to focus immunity on conserved proteome sequences; therefore, we selected four relatively conserved regions (Gag amino acids 148 to 214 and 250 to 335, Env amino acids 521 to 606, and Nef amino acids 106 to 148), each created in three mosaics, to provide better coverage of M-group HIV-1 sequences. A conserved-region vaccine (CRV) delivering genes for these four regions as equal mixtures of three mosaics each (each region at a separate injection site) was compared to a whole-protein vaccine (WPV) delivering equimolar amounts of genes for whole Gag, Env, and Nef as clade B consensus sequences (separate injection sites). Three rhesus macaques were vaccinated via three DNA primes and a recombinant adenovirus type 5 boost (weeks 0, 4, 8, and 24, respectively). Although CRV inserts were about one-fifth that of WPV, the CRV generated comparable-magnitude blood CD4+ and CD8+ T lymphocyte responses against Gag, Env, and Nef. WPV responses preferentially targeted proteome areas outside the selected conserved regions in direct proportion to sequence lengths, indicating similar immunogenicities for the conserved regions and the outside regions. The CRV yielded a conserved-region targeting density that was approximately 5-fold higher than that of the WPV. A similar pattern was seen for bronchoalveolar lymphocytes, but with quadruple the magnitudes seen in blood. Overall, these findings demonstrate that the selected conserved regions are highly immunogenic and that anatomically isolated vaccinations with these regions focus immunodominance compared to the case for full-length protein vaccination.

UR - http://www.scopus.com/inward/record.url?scp=84920842321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920842321&partnerID=8YFLogxK

U2 - 10.1128/JVI.02370-14

DO - 10.1128/JVI.02370-14

M3 - Article

C2 - 25378501

AN - SCOPUS:84920842321

VL - 89

SP - 1195

EP - 1204

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 2

ER -